Thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myeloma

Thrombotic thrombocytopenic purpura (TTP) and hemolytic-uremic syndrome (HUS) describe microvascular occlusive disorders characterized by thrombocytopenia due to increased platelet aggregation and fragmentation hemolysis. We report here what to our knowledge is the second case of TTP/HUS associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Salmenniemi, Urpu, Remes, Kari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401134/
https://www.ncbi.nlm.nih.gov/pubmed/22826795
http://dx.doi.org/10.4081/hr.2012.e13
_version_ 1782238571298553856
author Salmenniemi, Urpu
Remes, Kari
author_facet Salmenniemi, Urpu
Remes, Kari
author_sort Salmenniemi, Urpu
collection PubMed
description Thrombotic thrombocytopenic purpura (TTP) and hemolytic-uremic syndrome (HUS) describe microvascular occlusive disorders characterized by thrombocytopenia due to increased platelet aggregation and fragmentation hemolysis. We report here what to our knowledge is the second case of TTP/HUS associated with bortezomib treatment.
format Online
Article
Text
id pubmed-3401134
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher PAGEPress Publications
record_format MEDLINE/PubMed
spelling pubmed-34011342012-07-23 Thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myeloma Salmenniemi, Urpu Remes, Kari Hematol Rep Case Report Thrombotic thrombocytopenic purpura (TTP) and hemolytic-uremic syndrome (HUS) describe microvascular occlusive disorders characterized by thrombocytopenia due to increased platelet aggregation and fragmentation hemolysis. We report here what to our knowledge is the second case of TTP/HUS associated with bortezomib treatment. PAGEPress Publications 2012-06-29 /pmc/articles/PMC3401134/ /pubmed/22826795 http://dx.doi.org/10.4081/hr.2012.e13 Text en ©Copyright U. Salmenniemi and K. Remes, 2012 This work is licensed under a Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0). Licensee PAGEPress, Italy
spellingShingle Case Report
Salmenniemi, Urpu
Remes, Kari
Thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myeloma
title Thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myeloma
title_full Thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myeloma
title_fullStr Thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myeloma
title_full_unstemmed Thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myeloma
title_short Thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myeloma
title_sort thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myeloma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401134/
https://www.ncbi.nlm.nih.gov/pubmed/22826795
http://dx.doi.org/10.4081/hr.2012.e13
work_keys_str_mv AT salmenniemiurpu thromboticmicroangiopathyassociatedwithbortezomibtreatmentinapatientwithrelapsedmultiplemyeloma
AT remeskari thromboticmicroangiopathyassociatedwithbortezomibtreatmentinapatientwithrelapsedmultiplemyeloma

Ejemplares similares